FTM
IONS icon

First Turn Management’s Ionis Pharmaceuticals IONS Stock Holding History

First Turn Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-421,487
Closed -$18.3M – 39
2024
Q1 		$18.3M Buy
421,487
+64,808
+18% +$3.09M 2.73% 18
2023
Q4 		$18M Buy
+356,679
New +$17.1M 2.59% 23

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
TBC
Tweedy, Browne Co Stamford, Connecticut $1.26B AUM 33.88% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

First Turn Management's IONS Position: Q2 2024 in Review

First Turn Management sold out of Ionis Pharmaceuticals (IONS) in Q2 2024, closing a stake of 421,487 shares — an estimated $18.3M sold.

First Turn Management first reported a position in IONS in Q4 2023 and held it in 2 quarters. The position peaked at $18.3M in Q1 2024. 356 funds tracked by Wall St. Rank hold IONS as of Q2 2024.

  • First Turn Management reported no remaining Ionis Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • First Turn Management sold 421,487 Ionis Pharmaceuticals shares in Q2 2024, an estimated $18.3M.
  • First Turn Management first reported a position in Ionis Pharmaceuticals in Q4 2023 and held it in 2 quarters.
  • First Turn Management's Ionis Pharmaceuticals position peaked at $18.3M in Q1 2024.
  • 356 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2024.

Based on First Turn Management's 13F filing for Q2 2024, filed 8 Aug 2024.